Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07783737 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07783737 · ClinicalTrials.gov record · last posted 2026-08-25

China Glomerulonephritis Kidney Transplant Recipient Cohort: A Prospective Multicenter Observational Study

StatusNot Yet Recruiting
PhaseNot specified
Started2026-09-24
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This is a prospective observational study aimed at establishing a prospective observational cohort of patients with a confirmed diagnosis of glomerulonephritis (GN) before kidney transplantation in China. Information will be collected on the epidemiology of GN recurrence after kidney transplantation, as well as the outcomes and treatment of the primary disease following kidney transplantation, to provide evidence for subsequent clinical studies, drug development, and translational research. Approximately 300 patients with a confirmed diagnosis of GN before transplantation will be prospectively enrolled. Clinical data will be collected during screening, kidney transplantation, and a 3-year post-transplant follow-up. The frequency of follow-up visits is every 3 months in the 1st year after transplantation, and every 6 months during the 2nd to 3rd years, with a total of 8 follow-up visits. The study will be conducted at 10 sites across China.
Trial Details
NCT Number NCT07783737
Lead Sponsor AstraZeneca
Conditions Glomerulonephritis Kidney Transplant
Enrollment 300 participants
Start Date 2026-09-24
Primary Completion 2030-07-31 (estimated)
Study Completion 2030-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-25